Related Experiment Video
Updated: Apr 23, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
[Update on current care guideline: prostate cancer]
Abstract:
The annual incidence of prostate cancer (PC) in Finland was 4 700 (year 2010). The treatment decision is made together with the patient according to patient characteristics, cancer classification and recurrence risk rate. For local PC, recommended treatment is active surveillance, radical prostatectomy, radiation (+/- hormonal) therapy or hormonal therapy. Metastatic PC patients are treated with hormonal therapy. The aim for castrate resistant metastatic PC patients is to improve quality of life and relieve symptoms. The 5-year survival rate is 93 %. Follow-up is tailored individually. Population based PSA screening is not recommended.
More Related Videos
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Standards of Care II
Standards of Care I
Preventive Healthcare Services
Pre-Procedural Guidelines for Assessing Blood Pressure
Cancer Survival Analysis

